Results 141 to 150 of about 26,257 (175)
Some of the next articles are maybe not open access.
Inhibition of Apoptosis by Human T‐Lymphotropic Virus Type‐1 Tax Protein
Annals of the New York Academy of Sciences, 2003Abstract: Deregulation of the apoptotic process can lead to pathophysiological changes that result in either degenerative diseases or cancer. Although the transactivator Tax has been established as an essential effector of human T‐lymphotropic virus type‐1 (HTLV‐1)‐mediated diseases, which include both a neurodegenerative pathology and leukemia ...
Daniela, Saggioro +3 more
openaire +2 more sources
Human T-lymphotropic virus-1 serology in the Northern Territory: 2008–2011
Pathology, 2014A retrospective observational study of human T-lymphotropic virus-1 (HTLV-1) serology requests made to the Northern Territory Government Pathology Service (NTGPS) between 2008 and 2011, was undertaken to review aspects of HTLV-1 sero-epidemiology and performance of the assays.
R, Grivas, K, Freeman, R, Baird
openaire +2 more sources
Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control
International Journal of Hematology, 2003The human retrovirus human T-lymphotropic virus type 1 (HTLV-1) is associated with two distinct types of disease: the malignancy known as adult T-cell leukemia and a range of chronic inflammatory conditions including the central nervous system disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
openaire +2 more sources
Neurological Manifestations of the Human T-lymphotropic Virus Type 1
2017The human T cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects about 20 million individuals worldwide. Its typical neurological presentation is of a chronic, slowly progressive myelopathy named “HTLV-1-associated myelopathy/tropical spastic paraparesis” (HAM/TSP).
openaire +1 more source
Human T-Lymphotropic Virus 1, Breastfeeding, and Antiretroviral Therapy
AIDS Research and Human Retroviruses, 2015Fabio E, Leal +2 more
openaire +2 more sources
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Vikrant V Sahasrabuddhe +2 more
exaly